Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
18.35
+0.15 (0.82%)
Jun 18, 2026, 3:00 PM CST
-22.11% (1Y)
| Market Cap | 8.37B -16.9% |
| Revenue (ttm) | 1.42B -7.6% |
| Net Income | 110.05M +24.7% |
| EPS | 0.24 +25.2% |
| Shares Out | 455.90M |
| PE Ratio | 76.66 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,959,600 |
| Open | 18.15 |
| Previous Close | 18.20 |
| Day's Range | 18.01 - 18.76 |
| 52-Week Range | 17.98 - 32.99 |
| Beta | -0.08 |
| Analysts | Strong Buy |
| Price Target | 52.50 (+186.1%) |
| Earnings Date | Aug 28, 2026 |